# Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers

> **NCT01480648** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 74 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 144807 Placebo
- **DRUG:** BI 144807

## Key facts

- **NCT ID:** NCT01480648
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-02
- **Final completion:** —
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01480648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01480648, "Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01480648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*